Pavmed Inc (PAVM)

$1.73 0.08 (4.85%)

16:00 EDT PAVM Stock Quote Delayed 30 Minutes

PAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings May 14, 2024

PAVM stock results show that PAVmed beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

PAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

More Articles

Volume:

Previous Close -

Market Cap 16.32M

PE Ratio -0.15

EPS -11.6

Volume (Avg. Vol.) 44,610

Day's Range $1.65 - $1.80

52-Week Range $0.20 - $4.44

Dividend & Yield N/A (N/A)

PAVM Stock Predictions, Articles, and Pavmed Inc News

From InvestorPlace
From the Web

The 3 Most Undervalued Penny Stocks to Buy in December

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Dec 17, 2023

When economies are set to boom, undervalued penny stocks typically lead the way when it comes to equity rallies.

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential

By Josh Enomoto, InvestorPlace Contributor Dec 5, 2023

There are penny stocks and then are penny stock picks that are so outrageously wild that they should never be considered unless one is gambling…

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 14, 2023

It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!

3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024

By Alex Sirois, InvestorPlace Contributor May 24, 2023

These biotech stocks with high return potential are poised to provide quick returns for investors who invest over the next year.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jul 19, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer May 13, 2022

Good morning! We're starting off the final day of the work week with an overview of the biggest pre-market stock movers for Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 17, 2021

Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday!

PAVM Stock: One Big Reason Why PAVmed Is Plunging Today

By Chris MacDonald, InvestorPlace Contributor Oct 14, 2021

Today, a relatively disappointing start to trading for a PAVmed subsidiary, Lucid Diagnostics, is driving some bearish price action.

LUCD Stock IPO: 7 Things to Know as Lucid Diagnostics Starts Trading Today

By Chris MacDonald, InvestorPlace Contributor Oct 14, 2021

Unfortunately, today is a very red day for investors who got in on the recent LUCD stock IPO, with shares of this stock down more than 17%.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Sep 23, 2021

Good morning, investor! We're diving back into the stock market again today with a look at the biggest pre-market stock movers for Thursday!

PAVmed receives 180-day extension to regain compliance with Nasdaq rules (NASDAQ:PAVM)

From Seeking Alpha Jun 28, 2023

Medical technology company PAVmed (PAVM) said it has received a Nasdaq notice on having received a 180-day extension to regain compliance with Nasdaq rules.

PAVmed (NASDAQ:PAVM), units Lucid Diagnostics, Veris Health implement layoffs

From Seeking Alpha Jan 17, 2023

PAVmed (PAVM) on Tuesday, along with its units Lucid Diagnostics (LUCD) and Veris Health, announced strategic changes which include workforce reduction. Read more here.

PAVmed Digital Health subsidiary launches Veris cancer care platform (NASDAQ:PAVM)

From Seeking Alpha Dec 15, 2022

PAVmed (PAVM) said on Thursday digital health subsidiary Veris Health had commercially launched its Veris Cancer Care Platform. Veris CCP is a digital cancer care platform with...

Analysts Offer Insights on Healthcare Companies: Theravance Biopharma (TBPH), Cogent Biosciences (COGT) and PAVmed (PAVM)

From TipRanks Nov 17, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Theravance Biopharma (

Maxim Group Sticks to Their Buy Rating for PAVmed (PAVM)

From TipRanks Aug 18, 2022

In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on PAVmed (PAVM – Research Report), with a price target of $3.00. Th...

PAVmed: Q1 Earnings Insights

From Benzinga May 12, 2022

PAVmed (NASDAQ:PAVM) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings PAVmed beat estimated earnings by 30.0%, reporting an EPS of $-0.14 versus an estimate of $-0.2.

ADVERTISEMENT